comprehensive -WSS

comprehensive

author：explore 2025-10-02 13:14:30 - browse：73

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： The Sacklers, horror, and ‘The Fall of the House of Usher’

leisure time

WSS

At JPM 2024, hospital systems pitch financial strength to investors

Study suggests new cause of Down syndrome: cells linked to aging

MoonLake credibility takes another hit with mid

Senate panel clears PBM, hopsital reforms

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

MoonLake credibility takes another hit with mid

focus

comprehensive

knowledge

Peter Hotez and the public health issue of online harassment

MoonLake credibility takes another hit with mid

New air purifier tech could be key to improving indoor air quality

Senate panel clears PBM, hopsital reforms

Sports medicine is finally prioritizing gender equality

More doctors should go into startup world

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Will General Catalyst be the first of many hospital takeovers?

United colonoscopy coverage change 'may cost lives,' doctors say

Senate panel clears PBM, hopsital reforms

hotspot

Gene therapy denied for Afghan refugee whose father aided U.S.

Excited delirium, Elijah McClain, and emergency physicians

JPM pitch from hospitals? Revenue streams outside of patient care

Victims of gun violence feel impacts long after bullet wound

Boston Scientific acquires urology company Axonics for $3.7 billion

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

hotspot

leisure time

Wikipedia

entertainment